Correlation Between Aerovate Therapeutics and Marizyme

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Marizyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Marizyme into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Marizyme, you can compare the effects of market volatilities on Aerovate Therapeutics and Marizyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Marizyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Marizyme.

Diversification Opportunities for Aerovate Therapeutics and Marizyme

-0.47

Correlation Coefficient

Aerovate Therapeutics  Marizyme

Very good diversification

The 3 months correlation between Aerovate and Marizyme is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Marizyme in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marizyme and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Marizyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marizyme has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Marizyme go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Marizyme

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Marizyme. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 67.74 times less risky than Marizyme. The stock trades about -0.07 of its potential returns per unit of risk. The Marizyme is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  5.00  in Marizyme on December 1, 2024 and sell it today you would earn a total of  0.00  from holding Marizyme or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	96.77%
Values	Daily Returns

Aerovate Therapeutics  vs.  Marizyme

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Marizyme

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Marizyme are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Marizyme displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aerovate Therapeutics and Marizyme

The main advantage of trading using opposite Aerovate Therapeutics and Marizyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Marizyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marizyme will offset losses from the drop in Marizyme's long position.

The idea behind Aerovate Therapeutics and Marizyme pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.